Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach.

Accepted/In Press date: 8 June 2022

e-pub ahead of print date: 21 July 2022

Published date: September 2022

Additional Information: Funding Information: The ESCEO Working Group was funded by the ESCEO. The ESCEO receives unrestricted educational grants to support its educational and scientific activities from non-governmental organizations, not-for-profit organizations, non-commercial or corporate partners. The choice of topics, participants, content and agenda of the Working Groups as well as the writing, editing, submission and reviewing of the manuscript are the sole responsibility of the ESCEO, without any influence from third parties. Funding Information: NB, MCSR, MCPY, FD, CG, GHB, MCH, AL, RM, AM, JPP, RPR, FR, BU, DU, MV, RR, AM and CC report no conflict of interest. OB reports consulting or lecture fees for Amgen, Aptissen, Biophytis, IBSA, MEDA, Mylan, Novartis, Sanofi, Servier, SMB, TRB Chemedica, UCB, Viatris. EMD reports support from Pfizer, UCB, Lilly and Viatris. NF reports educational grants from Pfizer and Eli Lilly. IKH reports consultancies for Novartis and Abbvie, research grant from Pfizer (paid to institution), all outside of the submitted work. MH reports research grant through institution from Amgen, Radius Health, ViiV Healthcare, BD; lecture fees from Teva and Mylan Pharmaceuticals and consulting fees from UCB. EM reports consultancy or speaking fees for Abiogen, Expanscience, Fidia, Meda-Mylan, Pierre Fabre Labs, Sublimed, TRB Chemedica. JYR reports consulting fees or advisory board participation for IBSA-Genevrier, Mylan, Radius Health and Pierre Fabre, lecturing fees for IBSA-Genevrier, Mylan, Cniel and Dairy Research Council (DRC) and grant support from IBSA-Genevrier, Mylan, Cniel and Radius Health. NV reports participation in advisory boards for Mylan, Fidia, Sanofi-Aventis, Viatris, IBSA. Publisher Copyright: © 2022, Crown.

Keywords: Hand, Management, Osteoarthritis, Patient-centered, Treatment guideline

Local EPrints ID: 468729

URI: http://eprints.soton.ac.uk/id/eprint/468729

DOI: doi:10.1007/s40520-022-02176-y

ISSN: 1594-0667

PURE UUID: 631af749-f118-4100-b358-dbc4d5a4d6e7

ORCID for Nicholas Fuggle: orcid.org/0000-0001-5463-2255

ORCID for Elaine Dennison: orcid.org/0000-0002-3048-4961

ORCID for Cyrus Cooper: orcid.org/0000-0003-3510-0709

Date deposited: 24 Aug 2022 16:31

Last modified: 18 Mar 2024 03:49